Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,147.92 -13.95 -0.65%
FTSE 100 5,356.34 +4.81 0.09%
DAX 6,323.19 -16.75 -0.26%
Ticker Volume Price Price Delta
Nikkei 8,593.15 +12.76 0.15%
TOPIX 721.11 -1.00 -0.14%
Hang Seng 18,801.00 +87.58 0.47%
Gold 1,578.70 +0.48%
EUR-USD 1.2525 -0.1336%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,356.34 +0.09%
STOXX 50 2,147.92 -0.65%
DAX 6,323.19 -0.26%
Oil (WTI) 91.19 +0.36%
U.S. 10-year 1.738% 0.000
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
BREAKING NEWS
Japan April Jobless Rate is 4.6%; Economist Est. 4.5%

U.S. Sees Chavez in Critical State of Health in Cuba, Nuevo Herald Says

Venezuelan President Hugo Chavez is in a critical state of health after undergoing surgery in Cuba, El Nuevo Herald reported, citing unnamed U.S. intelligence sources.

The intelligence sources told the Spanish-language sister newspaper of the Miami Herald that, while Chavez isn’t in any immediate risk of dying, his situation is complicated. His daughter, Rosines Chavez, and ex-wife Marisabel Rodriguez were flown in a military aircraft to Havana in the last 72 hours to be by the president’s bedside, the newspaper reported.

The intelligence sources said they could not confirm that Chavez, who was last seen in public June 9, is suffering from prostate cancer as has been rumored in Caracas, El Nuevo Herald said.

Venezuela’s Foreign Minister Nicolas Maduro said yesterday Chavez needs the support of his compatriots in “this big battle for his health.” A lack of information surrounding Chavez’s surgery for what he said was a pelvic absceess has raised questions about the true state of his health and triggered debates about whether he should be running South America’s largest oil producer from Cuba.

To contact the reporter on this story: Charlie Devereux in Caracas at cdevereux3@bloomberg.net.

To contact the editor responsible for this story: Joshua Goodman at jgoodman19@bloomberg.net

Sponsored Links